Target intelligence / Profile preview

Ribosomal protein L22 pseudogene 7 (RPL22P7)

Target
RPL22P7
Molecular classification
Other (processed pseudogene)
01

Overview

Ribosomal protein L22 pseudogene 7 (RPL22P7) is a human processed pseudogene, meaning it is a non-functional, non-protein-coding genomic DNA segment derived from retrotransposition of the parent ribosomal protein L22 (RPL22) gene. RPL22P7 does not encode a functional protein and is part of a large family of ribosomal protein pseudogenes distributed throughout the human genome. While processed pseudogenes such as RPL22P7 can sometimes be mistakenly annotated as potentially functional loci, they generally do not participate in protein synthesis, have no established role as therapeutic targets, and lack known biological or pathological function[2][5][10]. Additional context: - Numerous processed pseudogenes exist for ribosomal proteins in the human genome; they arise from retrotransposition rather than conventional gene duplication, and most display sequence disablements such as frame shifts or premature stop codons[5]. - RPL22P7 is distinct from the functional RPL22 gene, whose canonical product integrates into the large 60S ribosomal subunit, playing a critical role in protein biosynthesis[1][3]. - The pseudogene status of RPL22P7 means that it should not be confused with functional ribosomal proteins or targets relevant for drug development or clinical monitoring.

Other names
RPL22_4_275RPL22P7
02

Biological functions

Other (as a pseudogene, it lacks known biological function; active RPL22 encodes a ribosomal protein, but RPL22P7 is nonfunctional)
03

Disease associations

Other (no direct disease association; some pseudogenes may be reported in genomic studies, but there is no evidence that RPL22P7 has a function or disease role)

Beyond the preview

Go deeper on Ribosomal protein L22 pseudogene 7 (RPL22P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L22 pseudogene 7 (RPL22P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call